Awakn Life Sciences Corp. (AWKNF)

USD 0.07

(0.0%)

Revenue Summary of Awakn Life Sciences Corp.

  • Awakn Life Sciences Corp.'s latest annual revenue in 2024 was 87.37 Thousand CAD , down -94.16% from previous year.
  • Awakn Life Sciences Corp.'s latest quarterly revenue in 2024 FY was 87.37 Thousand CAD , down -94.16% from previous quarter.
  • Awakn Life Sciences Corp. reported a annual revenue of 1.49 Million CAD in annual revenue 2023, up 533.52% from previous year.
  • Awakn Life Sciences Corp. reported a annual revenue of 236.03 Thousand CAD in annual revenue 2022, down 0.0% from previous year.
  • Awakn Life Sciences Corp. reported a quarterly revenue of 21.81 Thousand CAD for 2024 Q4, down -24.61% from previous quarter.
  • Awakn Life Sciences Corp. reported a quarterly revenue of 28.94 Thousand CAD for 2024 Q3, up 17.54% from previous quarter.

Annual Revenue Chart of Awakn Life Sciences Corp. (2024 - 2021)

Historical Annual Revenue of Awakn Life Sciences Corp. (2024 - 2021)

Year Revenue Revenue Growth
2024 87.37 Thousand CAD -94.16%
2023 1.49 Million CAD 533.52%
2022 236.03 Thousand CAD 0.0%
2021 - CAD 0.0%

Peer Revenue Comparison of Awakn Life Sciences Corp.

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.446%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -395.846%
SQZ Biotechnologies Company 21.47 Million USD 99.593%
Evofem Biosciences, Inc. 18.21 Million USD 99.52%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.929%
Mesoblast Limited 5.9 Million USD 98.52%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.987%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 78.698%
Marizyme, Inc. 645.81 Thousand USD 86.471%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -13.825%
Intellipharmaceutics International Inc. 65.72 Thousand USD -32.931%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -121.097%
MultiCell Technologies, Inc. 49.32 USD -177055.312%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.824%
EV Biologics, Inc. 48.9 Thousand USD -78.677%
Q BioMed Inc. 284.35 Thousand USD 69.273%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.705%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.964%
Oncotelic Therapeutics, Inc. 70 Thousand USD -24.819%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 11.739%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -15.383%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 86.732%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Halberd Corporation 999.00 USD -8646.046%
Enzolytics Inc. 52.79 Thousand USD -65.492%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 93.618%
SYBLEU INC 11.69 Thousand USD -647.033%
Nuo Therapeutics, Inc. 608.52 Thousand USD 85.642%
argenx SE 1.22 Billion USD 99.993%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 95.478%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 85.848%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.99%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.94%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 84.334%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 91.243%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.819%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 99.476%
ONE Bio Corp. 52.29 Million USD 99.833%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 63.065%
Regen BioPharma, Inc. 236.56 Thousand USD 63.065%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 37.698%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 81.556%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.878%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -572.1%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -121.007%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 97.376%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.689%
IntelGenx Technologies Corp. 1.03 Million USD 91.591%
Gelesis Holdings, Inc. 25.76 Million USD 99.661%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 88.427%